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Abstract
Background: Small for gestational age (SGA) leads to increased risk of adult obesity and metabolic syndrome.
Offspring exposed to 50% maternal food restriction in utero are born smaller than Controls (FR), catch-up in growth
by the end of the nursing period, and become obese adults. The objective of the study was to determine stearoyl-
CoA desaturase activity (SCD1) and rates of de novo fatty acid synthesis in young FR and Control offspring tissues
at the end of the nursing period, as possible contributors to catch-up growth.
Methods: From gestational day 10 to term, dams fed ad libitum (Control) or were 50% food-restricted to produce
small FR pups. Control dams nursed all pups. At postnatal day 1 (p1) and p21, offspring body tissues were analyzed
by GC/MS, and desaturation indices of palmitoleate/palmitate and oleate/stearate were calculated. SCD1 gene
expression was determined by real-time PCR on adipose and liver. Offspring were enriched with deuterium that
was given to dams in drinking water during lactation and de novo synthesis of offspring body tissues was
determined at p21. Primary adipocyte cell cultures were established at p21 and exposed to U
13C-glucose.
Results: FR offspring exhibited higher desaturation index in p1 and p21 adipose tissue, but decreased desaturation
index in liver at p21. SCD1 gene expression at p21 was correspondingly increased in adipose and decreased in
liver. FR subcutaneous fat demonstrated increased de novo synthesis at p21. Primary cell cultures exhibited
increased de novo synthesis in FR.
Conclusions: Adipose tissue is the first site to exhibit increased de novo synthesis and desaturase activity in FR.
Therefore, abnormal lipogenesis is already present prior to onset of obesity during the period of catch-up growth.
These abnormalities may contribute to future obesity development.
Background
Obesity is one of the most serious public health pro-
blems of the century. Currently, 65% of adults in the
United States are overweight, with 33% of adults [1] and
17% of children obese [2]. Obesity and its related dis-
eases are a leading cause of death in western society, as
obesity increases risk for hypertension, coronary heart
disease, stroke, and diabetes. As childhood obesity is a
major risk factor for adult obesity, the 17% incidence of
childhood obesity portends a further increase in the pre-
valence of adult obesity.
The Barker hypothesis of gestational programming is
supported by human epidemiologic and animal studies
which have convincingly demonstrated that low birth
weight and small for gestational age (SGA) newborns
have increased risk of adult obesity and metabolic syn-
drome [3-5]. Animal models of programmed obesity
produce SGA newborns who catch-up in growth by the
end of the nursing period, then develop adult obesity.
The mechanism(s) for programmed obesity in these ani-
mal models have been attributed to hyperphagia,
enhanced adipogenesis, hyperinsulinemia, and hyperlep-
tinemia [6,7]. The programmed offspring exhibit a phe-
notype of increased adipogenesis and adipocyte
differentiation and a propensity for fat storage.
Synthesis of fatty acids (via de novo lipogenesis in
liver and adipose) and triglycerides are important factors
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drome involve abnormalities in the liver, adipose tissue
and muscle, the organ-specific changes in lipogenesis
have not yet been studied. Triglycerides destined for fat
storage in adipose tissue are composed of fatty acids
from dietary sources and from de novo synthesis. De
novo synthesized fatty acids can undergo modification
through creation of double bonds via desaturation, and/
or further lengthening via chain elongation, thereby
implicating dysregulation of long chain fatty acid meta-
bolism in the mechanism of obesity.
Adipose tissue functions in lipid homeostasis to main-
tain energy balance through activities of the fatty acid
metabolic network. While de novo synthesis and chain
elongation promote energy storage, breakdown of fatty
acids by chain shortening and b-oxidation promote
energy release. Perturbation of the metabolic network
may shift the energy balance toward increased energy
release, or, as in obesity, increased energy storage. Meta-
bolite profiling of fatty acids can therefore provide
insights into abnormalities of lipogenesis. Notably,
in obese humans and animal models, stearoyl-CoA
desaturase enzyme 1 (SCD1), which converts saturated
palmitate (16:0), and stearate (18:0) to their monounsa-
turated products palmitoleate (16:1n-7) and oleate
(18:1n-9), respectively, is upregulated, and thus increases
the monounsaturated to saturated fatty acid ratio [7,8].
Monounsaturated fatty acids, such as palmitoleate and
vaccenate (18:1n-7, made from elongation of palmitole-
ate), but especially oleate, are preferred substrates for
triglyceride synthesis. Since triglycerides become incor-
porated into adipose tissue for storage, an increase in
the monounsaturated to saturated fatty acid ratio, there-
fore, increases propensity for fat storage.
Use of stable isotopes in profiling enables determina-
tion of de novo synthesis rates within a specified time
period in metabolically active tissues. Stable isotopes fre-
quently used in vitro and in vivo for study of fatty acid
metabolism include deuterium-enriched water (D20)
[9,10], and
13C-enriched glucose or fatty acids [11]. The
2Ho r
13C is incorporated during fatty acid synthesis
and therefore provides dynamic information on meta-
bolic activities that took place within the experimental
period.
We have established a rat model for nutritional pro-
gramming of adult obesity [6,12]. Our studies show that
offspring exposed to 50% maternal food restriction (FR)
in utero are SGA at birth. When nursed by normally fed
control dams, they exhibit rapid catch-up growth by 3
weeks of age. They subsequently develop adult obesity
with increased percent body fat and insulin resistance.
Importantly, the FR offspring exhibit increased expres-
sion of adipogenic genes and hypertrophic adipocytes
prior to onset of obesity [13] implicating increased
adipogenesis as a likely source of these abnormalities.
Whether changes in lipogenesis contribute to adipose
tissue development in FR is unclear.
Adipose, liver, and muscle can all exhibit dysregulated
lipogenesis in obesity. Nonetheless, the dynamics of tis-
sue-specific lipogenesis during the catch-up growth
phase have not been previously studied. We hypothe-
sized that enhanced lipogenesis during catch-up growth
contributes to programmed obesity. We utilized a meta-
bolomic approach to investigate pathways of fatty acid
synthesis in the same rat model that has been previously
well-described by our group [6,12-14]. We thus deter-
mined SCD1 activity and rates of fatty acid de novo
synthesis during the nursing period in major metabolic
tissues (adipose tissue, liver, muscle) and plasma prior
to onset of obesity in FR male offspring. Additionally,
we hypothesized that increased de novo synthesis in adi-
pose tissue is an intrinsic cellular response. Therefore,
we established adipose primary cell cultures from off-
spring to determine if increased de novo synthesis
would be enhanced under the cell culture system.
Methods
Animal studies
Studies received approval from the Animal Care Com-
mittee at the Los Angeles Biomedical Research Institute
at Harbor-UCLA and were in accordance with the
American Accreditation Association of Laboratory Care,
and conforming to the Public Health Service Policy on
Humane Care and Use of Laboratory Animals.
A description of the maternal food restriction (FR) rat
model has been previously published [6]. In brief, first-
time pregnant Sprague-Dawley rats (Charles River
Laboratories, Hollister, CA) were housed in an animal
facility that had controlled 12/12 hour light/dark cycles,
and were provided with constant temperature and
humidity conditions. On day 10 of gestation (e10), dams
were given either a standard laboratory ad libitum chow
diet (Lab Diet 5001, Brentwood, Missouri), or were 50%
food-restricted to produce SGA pups. Dams continued
the assigned diets during pregnancy and lactation. After
birth, on day 1 (p1), individual pups were weighed and
median weight obtained. To standardize nursing, litters
were culled to 8 pups per dam (4 males and 4 females)
to include the offspring of median weights. FR offspring
were cross-fostered to ad libitum-fed control dams (also
known as Cross-over dams). To control for cross-foster-
ing technique, the control pups were also cross-fostered
to Control dams.
Blood and Tissue Collection
1 day old pups were decapitated and plasma samples
were pooled per litter (males and females) and subcuta-
neous fat (SC fat), liver, and muscle were collected from
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for analysis. In all cases except liver, 6 litters per group
were studied. Livers from 6 pups in each group were
individually studied. Note that retroperitoneal (RP) fat
was not collected due to limited availability of this tissue
at this age.
At 3 weeks of age, male offspring (n = 5 Control, n =
6 FR) were weighed, anesthetized by 5% isoflurane/2%
oxygen by mask and blood collected via cardiac punc-
ture. Following this, animals were euthanized by an
overdose of pentobarbital (200 mg/kg i.p.) and tissues
(SC and RP fat, liver, and muscle) were collected and
snap-frozen in liquid nitrogen for analysis.
This manuscript describes studies on males only. Gen-
der differences in development of obesity exist in this
model so females were studied separately and will be
reported separately.
Deuterium Studies in Nursing Pups
Lactating dams nursing Control and FR pups (n = 8
each group) received deuterium as a stable isotope tra-
cer. On postnatal day 7 (p7), dams received a 2% (of
body weight) intraperitoneal injection of 99.9% deuter-
ium with 0.9% sodium chloride (normal saline). Then,
from p7 to p21, dams were provided 6% deuterium-
enriched drinking water. The concentration of deuter-
ium used was to maintain an approximate 3% body
water enrichment of deuterium. The deuterium enrich-
ment in offspring occurred through nursing and perhaps
a small contribution directly from drinking deuterated
water toward the end of the nursing period. Blood was
collected by tail bleeds on p12, p15, and p21 from lac-
tating dams which corresponded to days 5, 8, and 14 of
deuterium enrichment. At p21, male offspring were
sacrificed and blood and tissues (SC fat, RP fat, liver,
and muscle) were collected as stated above
Primary adipocyte cell cultures
Primary adipocyte cell cultures on RP fat were studied
to evaluate if differences between Control and FR could
be preserved, or enhanced in a cell culture system. At
p21, RP fat was collected from Control and FR males (n
= 8 per group). Pooled adipose tissue was minced,
digested with collagenase type II (5000 U/g) in Krebs-
Ringer solution for 30 min at 37°C, filtered through 200
μm mesh nylon filter and centrifuged at 500 × g for 5
min. The cells were resuspended in high glucose (450
mg/dl) DMEM (Invitrogen Carlsbad, CA) with 10% FBS
and 1% Antibiotic-Antimycotic (Invitrogen Carlsbad,
CA), seeded into flasks and incubated at 37°C and 5%
CO2. Following 100% confluence, adipocyte differentia-
tion was induced with dexamethasone (1 μM), methyli-
sobutylxanthine (0.1 mM), and insulin (10 μg/ml) for 10
days. After differentiation, cells were incubated with
high glucose DMEM medium containing 50% [U
13C]-
glucose. After 24 hours, cells were harvested and frozen
at -80°C for analysis.
Fatty acid extractions
Total fatty acids (phospholipids, triglycerides, cholesteryl
esters and free fatty acids) were extracted from plasma,
tissues, and cells from adipocyte cultures, using a
method by Lowenstein et al [15]. Briefly, tissue (~50 mg
liver or muscle; ~30 mg adipose tissue) or plasma sam-
ples (50 μl), or adipocytes were saponified in 200 proof
ethanol and 30% KOH (w/v) in a 1:1 volume overnight
on a 70°C heating block. Samples were acidified with
HCl, fatty acids were extracted three times with petro-
leum ether and air dried. Fatty acids were derivatized as
methyl esters using 0.5 N methanolic HCl, dried under
a nitrogen stream and subsequently reconstituted with
hexane for gas chromatography/mass spectrometry (GC/
MS) analysis.
For fatty acid quantification, SC fat was cut and
weighed, then saponified with a known quantity of hep-
tadecanoic acid-d3 (tri-deuterated) as an internal
standard.
Gas chromatography/mass spectrometry
GC/MS analysis was carried out using a Hewlett-Pack-
ard model 5973 selective mass detector connected to a
model 6890 gas chromatograph. Fatty acids were ana-
lyzed as their methyl esters after derivatization. Palmi-
tate, palmitoleate, stearate, oleate, and vaccenate were
separated on the gas chromatograph with a Bpx70 col-
umn (30-m length, 250- μm diameter, 0.25- μm film
thickness) from SGE, Inc. (Austin, TX). The GC condi-
tions were as follows: helium flow rate, 1 ml/min; initial
oven temperature, 150°C, which was programmed to
increase at 3°C/min to a final temperature of 221°C. The
expected retention times for palmitate, palmitoleate,
stearate, oleate, and vaccenate under these conditions
were as follows: 6.5, 7.1, 9.4, 10.0, and 10.1 min, respec-
tively. Mass spectra of fatty acids were acquired using
electron impact ionization and selective ion monitoring.
Ion clusters monitored for the quantitation of isotopo-
mers were mass-to-charge ratio (m/z) 270 for palmitate,
m/z 298 for stearate, m/z 264 for oleate. Distribution of
the mass isotopomer was determined from the spectral
data using a method previously described by Lee et al
[16] that corrects for the contribution of derivatizing
agent and
13C natural abundance to the mass isotopo-
mer distribution of the compound of interest. Each
compound of interest includes the sum of isotopomer
peaks within a cluster. The resulting mass isotopomer
distribution was expressed in molar fractions (m0, m1,
m2, m3, etc.) corresponding to the fraction of molecules
that contain 0, 1, 2, 3, ...deuterium substitutions.
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The distribution of the fatty acids of interest observed
by gas chromatography are presented graphically. By
convention, each fatty acid is expressed as a relative per-
centage normalized to palmitate in the same tissue, with
palmitate set at 100%.
Desaturation Index
The desaturation index is the ratio of monounsaturated
fatty acid to corresponding saturated fatty acid deter-
mined by the integrated areas under the gas chromato-
gram peaks. The ratios of palmitoleate/palmitate (16:1/
16:0), oleate/stearate (18:1n-9/18:0), and vaccenate/stea-
rate (18:1 n-7/18:0) were determined for this study
a.
Stearate/palmitate ratio
Stearate can be made directly from de novo synthesis or
from chain elongation of palmitate. The stearate/palmi-
tate ratio was determined to represent production and
disappearance of stearate relative to production and dis-
appearance of palmitate.
Calculation of de novo synthesis and acetyl-CoA
enrichment in primary adipocyte cell cultures using U
13C-
glucose
Precursor acetyl-CoA enrichment was calculated from
the consecutive mass isotopomer ratio M+4/M+2 of pal-
mitate and M+6/M+4 of stearate, from incorporation of
[1,2-
13C] acetate produced from U
13C-glucose in the
medium. The fraction of new synthesis was calculated
using mass isotopomer distribution analysis (MIDA)
[11], as previously described. These calculations used
information from the “light” fraction of molecules with
peaks corresponding to m2,m 4,a n dm 6 molecules from
incorporation of [1,2-
13C]acetyl-CoA in de novo synth-
esis of palmitate and stearate [16,17].
Calculation of de novo synthesis in deuterium studies
The fraction of new synthesis (FNS) representing de
novo synthesis was calculated using previously described
methods [18,19]. Briefly, FNS = ME(fatty acid)/(p × N),
in which ME (molar enrichment) is the average number
of deuterium atoms incorporated per molecule calcu-
lated from mass isotopomer distribution, p is the deu-
terium enrichment (specific activity) in water which is
determined using the m2/m1 consecutive mass isotopo-
mer ratio, and N is the number of deuterium per mole-
cules incorporated from body water per molecule of
fatty acid (e.g. 21 for palmitate).
For quantification of fatty acids made over the 14 day
period, the amounts of palmitate, stearate, and oleate
per mg of SC fat were first determined based on GC
peak areas relative to the heptadecanoic acid-d3 internal
standard, and then calculations were made using the
FNS. The amounts of fatty acids made are expressed as
the average amounts made per mg of fat tissue per day.
SCD1 mRNA expression by real-time PCR
RNA was extracted from adipocytes using the Qiagen
RNeasy Lipid Tissue Mini Kit, then DNase-treated
(Ambion Turbo DNA-free kit). RNA concentration was
determined on the Nanodrop 2000 spectrophotometer
(Thermo Scientific). cDNA was made with 2 μgo fR N A
using the Invitrogen Superscript III First Strand Synthesis
System for RT-PCR. SCD1 primers were generated from
NCBI reference sequence [NCBI: NM 139192.2] by Primer
Express software (Applied Biosystems). SCD1 forward
primer sequence 5’®3’: CAGAGCCAGGTGCCACTTTT;
SCD1 reverse primer sequence 5’®3’:T G C T A -
GAGGGTGTACCAAGCTTT. 18S was used as the refer-
ence gene. 18S forward primer sequence 5’®3’CTTAGAG
GGACAAGTGGCG; 18S reverse primer sequence
5’®3’GGACATCTAAGGGCATCACA. Real-time PCR
was performed using SYBR Green reporter dye on the ABI
Prism 7000 sequence detection system with annealing
temperature of 60°C, along with 18S as the reference gene.
Results were converted to ΔΔCt values, and expression of
SCD1 was normalized to 18S levels. SCD1 expression in
FR is presented as fold change relative to Controls.
Statistical Analysis
Data are presented as the mean, ± SE. Comparisons are
made between Control and the FR group using unpaired
t-test.
Results
Metabolic Phenotype - In Vivo
Rat Offspring Weights
There was no difference between Control and FR litter
sizes at birth. As previously published, FR offspring were
s m a l l e rt h a nC o n t r o l sa tp 1( 5 . 2±0 . 2v s7 . 0±0 . 3g m )
[6]. When nursed normally, FR offspring body weights
were similar to the controls at p21 (FR 42.2 ± 2.0 vs
Controls 48.5 ± 3.3 gm).
Dam Weights
No differences between Control and Cross-over dam
weights were present during lactation. At p1, Control
and Cross-over weights were, respectively, 297.6 ± 5.3
and 298.1 ± 6.6 gms, and both groups gained weight
during early lactation. At p14, Control and Cross-over
dam weights were 340.3 ± 6.2 and 351.2 ± 6.8 gms. At
p20, the weights had decreased to 334.0 ± 5.7 and 345.1
± 7.8 gms, respectively. Upon sacrifice at p21, no visible
milk globules were readily available for collection from
the mammary tissue.
Fatty acid profile
In general, gas chromatography peaks were observed for
the following saturated fatty acids: (myristate, 14:0;
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(palmitoleate 16:1n-7; oleate, 18:1n-9; vaccenate, 18:1n-
7). The fatty acid distribution exhibited tissue and age
specificity as described below.
Dams The plasma fatty acid profile was comparable in
both groups of dams. At p12 and p15 palmitate and
stearate levels were similarly high though at p21, stea-
rate was the most prominent fatty acid (Figure 1).
Offspring At p1 (Figure 2), in both FR and Controls,
oleate was the most abundant fatty acid in SC fat,
whereas palmitate was the most abundant in liver, mus-
cle and plasma. Comparison between FR and Controls
at p1 revealed a significant decrease in SC fat
palmitoleate.
At p21 (Figure 3), in both FR and Controls, oleate and
palmitate were the most prominent fatty acids in SC
and RP fat. In liver, stearate was the most prominent
fatty acid, while in muscle and plasma, palmitate contin-
u e dt ob em o r ep r o m i n e n t .C o m p a r i s o no fF Ra n d
Controls at p21 revealed that FR exhibited increased
palmitoleate in SC fat, decreased oleate in liver, but
increased stearate in liver.
Desaturation indices
Desaturation indices are expressed in arbitrary units, ±
standard error of the mean.
Dams At p12, there were no other differences in
the desaturation indicies other than a slight increase in
the oleate/stearate ratio in Cross-Over dams at p12
(Table 1).
Offspring At p1, SC fat and plasma both exhibited
increased oleate/stearate ratios in FR (Table 2). Interest-
ingly, SC fat palmitoleate/palmitate ratio was signifi-
cantly decreased in FR. No differences were seen in liver
and muscle.
At p21 (Table 3), both SC and RP fat in FR exhibited
changes consistent with obesity; there was a marked
increase in all three desaturation indices (palmitoleate/
palmitate, oleate/stearate, vaccenate/stearate). In
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Figure 1 Fatty acid distribution represented as percent of palmitate in dam plasma on p12, p15, and p21. Black bars represent the
Control dams, and gray bars the Cross-Over dams. Stearate is similarly prominent as palmitate in the dams until p21, when stearate becomes
the most prominent fatty acid.
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rate and vaccenate/stearate. No differences were evident
either in plasma or muscle desaturation indices between
the two groups.
Stearate/palmitate ratio
Dams There were no differences in the stearate/palmi-
tate ratio (Table 1).
Offspring At p1, the stearate/palmitate ratio was not sig-
nificantly different between FR and Controls (Table 2).
At p21 (Table 3), only FR liver exhibited an increased
ratio.
SCD1 mRNA expression by real-time PCR
3 week old FR offspring demonstrated a strong trend to
an increase in SCD1 mRNA expression in SC fat (Figure
4), with FR expression 1.65 times that of Controls (A).
FR demonstrated a significant decrease in liver, with
expression 0.28 times that of Controls (B).
De novo fatty acid synthesis
Deuterium enrichment in body water reached a plateau
of about 3-4% in the fatty acids of all offspring tissues
and dam plasma, with no differences between Control
and FR offspring, or Control and Cross-Over dams (data
not shown).
Dams In both groups (Table 4), the pattern of fatty acid
FNS was similar at p12 and p15, with all three fatty acids
in similar ranges. However, at p21, the oleate FNS in
both groups decreased in abundance compared to palmi-
tate and stearate. There were no differences between
Control and Cross-over groups in the FNS of the fatty
acids at any time point. Dam plasma fatty acid FNS at
p21 were all higher than offspring plasma FNS (Figure 5).
Offspring The pattern of FNS was similar in all tissues
with palmitate being the most abundant followed by
stearate and oleate. At p21, FNS of palmitate in SC fat
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Figure 2 Fatty acid distribution in p1 body tissues, expressed as percent of fatty acids normalized to palmitate, with palmitate set at
100%. Black bars represent the Control group, and gray bars the FR group. *p < 0.05 when comparing the two groups. Tissues were from p1
males except for plasma which was pooled males and females. In SC fat (A), oleate was the most prominent fatty acid in both Control and FR
groups. In SC Fat, percent of palmitoleate was decreased in FR versus Controls. In liver (B), plasma (C), and muscle (D), palmitate was the most
prominent fatty acid, followed by stearate, and then oleate.
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Figure 3 Fatty acid distribution at p21 in various tissues. The percent of fatty acid is normalized to that of palmitate. Black bars represent
the Control group, and gray bars the FR group. *p < 0.05 and **p < 0.01 when comparing the two groups. The fatty acid distribution was
similar between the SC fat (A) and RP fat (B). In liver, stearate was increased but oleate was decreased in FR compared to Controls. The fatty acid
distribution of plasma (D) and muscle (E) were similar. The trend toward differences between FR and Control stearate and oleate in plasma (D)
appeared to reflect the differences in liver (C).
Table 1 The desaturation indices and the stearate/palmitate ratio for rat dam plasma on p12, p15, and p21.
Palmitoleate/Palmitate Ratio Oleate/Stearate Ratio Vaccenate/Stearate Ratio Stearate/Palmitate Ratio
Day Control Cross-Over Control Cross-Over Control Cross-Over Control Cross-Over
p12 0.040 ± 0.002 0.046 ± 0.004 0.48 ± 0.02 0.55 ± 0.03* 0.080 ± 0.004 0.088 ± 0.004 1.03 ± 0.04 1.00 ± 0.01
p15 0.042 ± 0.001 0.043 ± 0.002 0.54 ± 0.03 0.57 ± 0.02 0.096 ± 0.002 0.096 ± 0.003 0.98 ± 0.03 1.03 ± 0.02
p21 0.045 ± 0.004 0.050 ± 0.004 0.52 ± 0.05 0.53 ± 0.03 0.095 ± 0.006 0.082 ± 0.005 1.18 ± 0.05 1.22 ± 0.04
*Mean p < 0.05 in comparison to Control group
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(Table 4). There was a strong trend to an increase in
palmitate made per mg of SC fat per day in FR offspring
(Table 5).
Metabolic Phenotype - Primary Adipocyte Cell Cultures
(In vitro)
De novo fatty acid synthesis
Although the in vivo study showed no difference in de
novo synthesis of fatty acids in RP fat from Control and
FR offspring, exposure of adipocytes to high glucose
medium in cell culture delineated distinct differences
between the groups. FR offspring exhibited increased
FNS of palmitate and stearate as Controls, but similar
FNS of oleate (Table 6).
Acetyl-CoA Enrichment
The acetyl-CoA enrichment represents glucose utiliza-
tion toward fatty acid synthesis. Consistent with the
FNS in vitro, the acetyl-CoA enrichment for palmitate
was increased in the FR offspring (Table 6).
Discussion
The novel approach of metabolic profiling combined
with stable isotope use demonstrated increased lipogen-
esis in adipose tissue during the catch-up growth phase
in the maternal food restriction model of programmed
obesity. Since the programmed FR offspring continue to
grow and surpass Controls to have increased fat mass in
adulthood, this increased lipogenesis is a potential con-
tributor to the development of obesity.
The rat dam plasma fatty acid profile and desaturation
index may be thought to influence the offspring fatty
acid profiles through nursing. The dam plasma measure-
ments were determined at several time points not only
to track increasing deuterium enrichment, but also to
observe whether increased demand for lactation from
hyperphagic FR offspring [14] led to any differences in
maternal fatty acid profiles. There was only one time-
point, p12, during which the oleate/stearate ratio was
increased in Cross-Over dams, suggesting that FR off-
spring demand can affect milk fatty acid composition.
However, this was an isolated difference, and fatty acid
profiles and desaturation indices were similar at p21 and
therefore could not account for differences between
Control and FR offspring at p21. Whether or not the
transiently increased desaturation index correlates to
any physiologic changes in the offspring (such as rate of
growth at p12) would require further studies.
The dam plasma FNS levels were more prominent
than those of the respective offspring fatty acids, which
suggests that dam FNS possibly contributes significantly
to offspring FNS. However, maternal FNS again does
not account for differences between Control and FR off-
spring. Instead, the dam FNS pattern appears consistent
with demand for fatty acids for lactation, with oleate
FNS being the most prominent on p15, but decreasing
dramatically by p21. The maternal weights in both
groups decreased during this time. Therefore, the
decreased oleate FNS suggests dilution of the deuterated
oleate pool by recycling mobilization from adipose tissue
Table 2 The desaturation indices and the stearate/palmitate ratio at p1
Palmitoleate/Palmitate Ratio Oleate/Stearate Ratio Vaccenate/Stearate Ratio Stearate/Palmitate Ratio
Body Tissue Control FR Control FR Control FR Control FR
SC Fat 0.09 ± 0.003 0.07 ± 0.003* 4.94 ± 0.22 5.53 ± 0.09* 0.48 ± 0.02 0.47 ± 0.02 0.28 ± 0.01 0.26 ± 0.02
Liver 0.009 ± 0.001 0.016 ± 0.0005 0.75 ± 0.1 0.95 ± 0.2 0.16 ± 0.02 0.19 ± 0.03 0.57 ± 0.06 0.59 ± 0.1
Plasma
b 0.02 ± 0.002 0.03 ± 0.01 0.20 ± 0.04 0.37 ± 0.06* 0.07 ± 0.03 0.04 ± 0.01 0.56 ± 0.01 0.70 ± 0.10
Muscle 0.031 ± 0.004 0.026 ± 0.001 0.85 ± 0.12 0.70 ± 0.07 0.14 ± 0.03 0.16 ± 0.01 0.81 ± 0.08 0.88 ± 0.04
*p < 0.05 in comparison to Control group
bSC fat, liver, and muscle are from males, and plasma is pooled from males and females due to small volumes in these animals at this age.
Table 3 The desaturation indices and the stearate/palmitate ratio in p21 offspring tissues.
Palmitoleate/Palmitate Ratio Oleate/Stearate Ratio Vaccenate/Stearate Ratio Stearate/Palmitate Ratio
Body Tissue Control FR Control FR Control FR Control FR
SC Fat 0.041 ± 0.007 0.046 ± 0.008* 3.23 ± 0.005 3.51 ± 0.001* 0.29 ± 0.004 0.31 ± 0.006* 0.27 ± 0.008 0.25 ± 0.006
RP Fat 0.037 ± 0.003 0.043 ± 0.002
¥ 2.85 ± 0.11 3.19 ± 0.11* 0.27 ± 0.01 0.30 ± 0.01* 0.31 ± 0.02 0.28 ± 0.01
Liver 0.0061 ± 0.0005 0.0059 ± 0.0001 0.25 ± 0.04 0.19 ± 0.02* 0.049 ± 0.003 0.046 ± 0.001 1.38 ± 0.03 1.51 ± 0.07*
Plasma 0.036 ± 0.003 0.031 ± 0.002 1.07 ± 0.15 0.80 ± 0.08 0.11 ± 0.01 0.09 ± 0.01 0.74 ± 0.06 0.80 ± 0.05
Muscle 0.025 ± 0.003 0.029 ± 0.002 1.17 ± 0.17 1.24 ± 0.09 0.16 ± 0.01 0.17 ± 0.01 0.65 ± 0.06 0.61 ± 0.04
* p < 0.05 in comparison to Control group
¥ p = 0.05
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Page 8 of 13since oleate is a major component of adipose tissue fatty
acids. By p21, the dams may be mobilizing its preexist-
ing fat stores in order to keep up with demand for ole-
ate for lactation at this age.
The desaturation index is increased in animal models
of obesity [20] and obese humans [8]. The desaturation
index has been shown to correlate with SCD1 mRNA
expression, protein expression, and enzyme activity [21]
and is therefore a good measure of SCD1 activity. We
observed differences in the desaturation indices between
Controls and FR offspring at p1 and p21. In p1 SC fat,
FR exhibited an increased oleate/stearate desaturation
index, and decreased palmitoleate/palmitate index.
While the opposing directions of the two desaturation
pathways appear in conflict with obesity studies on
SCD1 activity (increased in obesity), our findings sup-
port data that the palmitate-to-palmitoleate desaturation
pathway is compartmentalized from the stearate-to-ole-
ate pathway [11,22]. Moreover, palmitoleate has recently
been suggested to function as a “lipokine” [23] with
anti-inflammatory properties, communicating as a sig-
naling hormone to liver and muscle to improve insulin
sensitivity. In this context, the reduced adipose
palmitoleate/palmitate desaturation index at p1 may
therefore be consistent with increased metabolic risk.
The p21 desaturation pattern and fatty acid profile
suggest physiologic changes by p21. At p21, the
increased oleate/stearate and vaccenate/stearate desa-
turation indices in FR SC and RP fat, accompanied by
the strong trend to increased SCD1 expression in SC
fat, implicate SCD1 activity in the ultimate development
of adiposity. In contrast, the liver has a decreased ole-
ate/stearate ratio with a corresponding increased stea-
rate/palmitate ratio, suggesting an accumulation of
stearate from lack of desaturation. While it has been
shown that starvation decreases hepatic SCD1 gene
expression [24], our FR offspring continue to exhibit
lower SCD1 activity accompanied by lower SCD1 gene
expression during normal nursing, suggesting a pro-
grammed effect from the nutrient deprivation. The
increased palmitoleate/palmitate ratio in FR SC fat at
p21 indicates that SCD1 is under the influence of differ-
ent factors at p21 versus p1, altering the palmitoleate
proportions during these two ages. An important factor
is likely the difference in nutrient exposure during these
two time points. It has been suggested that palmitoleate
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Figure 4 SCD1 mRNA expression in FR and Control offspring at p21 in A) SC fat and B) liver. Corresponding to the desaturation indices,
SCD1 mRNA expression in FR demonstrates a strong trend toward an increase in SC fat (p = 0.06), and a significant decrease in liver (*p < 0.05).
Table 4 The fraction of new synthesis (FNS) of palmitate, stearate, and oleate in p21 offspring and dam plasma
Control FR or Cross-over
Body Tissue FNS Palmitate (%) FNS Stearate (%) FNS Oleate (%) FNS Palmitate (%) FNS Stearate (%) FNS Oleate (%)
Dams Plasma p12 44.1 ± 1.7 40.9 ± 2.1 44.7 ± 1.7 44.9 ± 1.6 46.1 ± 2.0 42.3 ± 1.6
Plasma p15 46.6 ± 1.6 42.9 ± 1.8 52.9 ± 2.1 47.3 ± 1.2 46.0 ± 1.9 50.7 ± 2.1
Plasma p21 50.7 ± 2.7 50.2 ± 2.2 32.3 ± 3.2 53.9 ± 2.6 52.4 ± 3.5 37.3 ± 3.5
Offspring SC Fat 40.0 ± 1.4 22.5 ± 1.1 17.8 ± 1.0 43.5 ± 1.1* 24.1 ± 1.0 17.6 ± 1.2
RP Fat 42.5 ± 1.3 25.7 ± 0.7 20.5 ± 0.7 44.1 ± 1.7 26.2 ± 1.2 19.3 ± 0.7
Liver 44.9 ± 0.8 35.3 ± 0.8 27.7 ± 0.2 46.1 ± 1.3 36.2 ± 1.2 25.9 ± 0.6
Plasma 39.1 ± 1.1 30.2 ± 0.9 19.8 ± 1.1 41.2 ± 1.3 30.5 ± 1.0 19.2 ± 1.7
Muscle 46.8 ± 0.8 30.1 ± 0.5 29.6 ± 0.5 46.7 ± 1.2 30.5 ± 0.9 27.0 ± 1.2
*p < 0.05 in comparison with Control group
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Page 9 of 13produced by fat tissue may provide negative feedback to
t h el i v e r[ 2 5 ] ,s u p p r e s s i n gS C D 1 .O u rf i n d i n go f
decreased liver oleate/stearate ratio at p21 would appear
to be consistent with this hypothesis. However, the
biological functions of palmitoleate are still largely
unknown and the mechanisms behind the fatty acid
metabolic differences seen at p21 versus p1 require
further investigation. Whether these differences in tissue
desaturation indicies persist in adulthood also requires
investigation.
Use of deuterium-enriched water is a useful technique
for demonstrating the rate of fatty acid synthesis during
a specified time period. Deuterium studies, for example,
have enabled determination of de novo synthesis pat-
terns during early life and in response to high-fat feed-
ing in the Zucker rat model of obesity and leptin
resistance. Zucker pups have increased de novo lipogen-
esis in adipose tissue leading to increased triglyceride
synthesis during the early suckling period [10], and
increased adipocyte hyperplasia after adolescence. As
obese adults, the Zucker rat does not suppress its de
novo lipogenesis after high fat feeding [26]. For perspec-
tive, additional examples of de novo synthesis rates
determined after deuterium enrichment in different
types of rat tissues are shown in Table 7.
In our study, measurement of de novo synthesis over
14 days during the nursing period revealed information
on fatty acid turnover. In both Controls and FR, the
FNS of palmitate was most prominent, followed by stea-
rate, then oleate, indicating that FNS palmitate is least
diluted by preexisting palmitate, but stearate and oleate
exhibit more dilution by their preexisting pools. A less
abundant FNS oleate in SC and RP fat compared to
muscle and liver indicate higher turnover and recycling
of preexisting oleate in the fat. Though de novo synth-
esis (and accumulation of dietary fatty acids) appears
active in all tissues at p21, differences among the tissues
in fatty acid synthesis and mobilization are evident.
Determination of de novo synthesis during 14 days of
the catch-up growth period also revealed an increase in
FNS of palmitate at p21 in offspring SC fat. As pre-
viously discussed, the dam FNS contribution does not
account for the FNS difference in FR offspring. There-
fore, SC fat is the first site to exhibit programmed
abnormal lipogenesis in this model. The high fat diet of
dam’s milk (protein 24.6%, fat 69.5%, carbohydrates
5.9%) [27] would be expected to suppress offspring de
novo lipogenesis, but it failed to suppress it in the FR
group to the same degree as the Control group.
There was a strong trend to an increase in the average
amount of palmitate made per mg of SC fat per day
in FR compared to Controls. This was averaged from
t h ea m o u n tm a d eo v e ra1 4d a yp e r i o d ,a n dd o e sn o t
account for day-to-day variation in production. This
result is consistent with increased lipogenesis during
catch-up growth in FR offspring. However, it does not
represent total palmitate made in the fat pads per day,
which could not be determined within the scope of the
present study.
The deuterium tracer study is limited in that it cannot
determine the original site of de novo synthesis. It is
possible that fatty acids are synthesized in one organ
and then circulated through the bloodstream to be
taken up by another organ. Therefore, enhanced fatty
acid uptake in FR adipocytes remains a possibility. How-
ever, the data from the retroperitoneal primary adipo-
cyte cell cultures supports actual differences in de novo
synthesis since the cultured adipocytes have been
removed from the influence of other organs.
Although the RP fat did not show increased FNS in
vivo, the primary adipocyte cell cultures revealed
increased de novo lipogenesis after exposure to high
glucose medium, which may reflect the cells’ response
under conditions of nutrient excess. The increased
acetyl-CoA enrichment further supports the increased
propensity to utilize glucose toward fat storage. These
findings support the differences as programmed effects
that are manifested in over-nutrition. The differences in
de novo synthesis between FR and Controls therefore
Table 5 Average amounts of fatty acids made per mg of
SC fat per day
Average made per mg of tissue per day (μg/mg/day)
Fatty Acid Control FR
Palmitate 3.19 ± 0.22 3.85 ± 0.16
¥
Stearate 0.36 ± 0.03 0.40 ± 0.06
Oleate 1.02 ± 0.02 1.08 ± 0.03
¥ p = 0.06 in comparison with Control group
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Figure 5 The FNS of palmitate, stearate, and oleate, for the
plasma of dams and offspring at p21. The FNS of all three fatty
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Page 10 of 13may not only be a failure to equally suppress de novo
lipogenesis under the high fat diet of dam’s milk. Alter-
natively, the differences may be mediated by the
increased insulin sensitivity at this age in FR. Further
studies are needed to establish the mechanisms by
which de novo synthesis is increased.
The increased de novo synthesis in FR adipose tissue
during the catch-up growth phase suggests this as the
time to intervene to prevent obesity. In adult humans,
there is suggestion that de novo synthesis in adipose tis-
sue and the liver may not be a significant contributor to
development of obesity [28,29]. However, the role of de
novo synthesis may differ in adulthood and infancy.
While there is limited tracer-based data showing active
substantial de novo synthesis in infancy [30] and ethical
considerations in studying infant tissues, de novo synth-
e s i sm a yb eam o r es i g n i f i c a n tc o n t r i b u t o ra tay o u n g
age prior to development of adiposity [10]. Therefore,
inhibiting de novo synthesis may potentially be an effec-
tive intervention in early life, but not in adulthood.
Nutrient restriction prenatally programs the offspring
fatty acid metabolism, but the outcome of the program-
ming is dependent upon postnatal nutritional influences.
Food-restriction during late gestation leads the off-
spring’s metabolism to adapt to conditions of under-
nutrition. During this key developmental phase, the FR
offspring is able to reset its balance of energy intake and
energy expenditure in anticipation of continuous under-
nutrition, optimizing its survival as an adult. This antici-
patory physiologic adaptation has been described as the
“predictive adaptive response [31].” After birth, however,
unexpected exposure to normal nutrition becomes inter-
preted as over-nutrition, and is therefore a “mismatch
[31]“ for its metabolism. The FR offspring therefore uti-
lizes the excess energy intake for fat storage, with
increased fatty acid de novo synthesis and desaturation
in adipose tissue (Figure 6). In human infants born
SGA, feeding on nutrient-enriched formula (compared
to feeding on control formula) led to increased early
weight gain, which was associated with increased fat
mass in childhood [32]. Consequently, encouraging early
catch-up growth by increasing energy intake leads to
over-nutrition for the SGA infant who has adapted to
conditions of under-nutrition. Prenatal adaptation,
therefore, should definitely be considered in optimizing
nutrition for infants born at metabolic risk.
Conclusion
In summary, increased oleate/stearate desaturation index
is present in p1 and p21 FR adipose tissue prior to the
onset of obesity. Decreased palmitoleate/palmitate ratio
at p1 in contrast to an increased ratio at p21 implicates
presence of different factors influencing desaturase
activity at the two ages. At p21, there is also increased
de novo synthesis in the SC fat in vivo, and in the RP
fat in vitro. These differences cannot be explained by de
Table 7 De novo synthesis rates after varying periods of deuterium enrichment in rat tissues
Source of Data and
Species
Tissue % Deuterium in
drinking water
p
(% enrichment
in plasma water)
Days of
enrichment
FNS Palmitate
(%)
FNS Stearate
(%)
Lee et al, AJP, 1994 [34]
Sprague-Dawley
young adult
Liver 4% 2.5 7 days 48.53 39.77
2.47 14 days 39.57 31.67
2.76 28 days 43.83 32.42
2.8 56 days 50.17 37.07
Bassilian et al, AJP, 2002
[35]
Zucker lean
Plasma
triglycerides
6% Not provided 14 days 70.70 61.03
Epididymal fat 6% Not provided 14 days ~18* ~12*
Ajie et al, AJP, 1995 [36]
HRS/J and Sprague-
Dawley
Spinal cord 4% Not provided 56 days 79.35 65.66
* inferred from graph
Table 6 Fraction of new synthesis of fatty acids and acetyl-CoA enrichment of palmitate in primary adipocyte cell
cultures
FNS Palmitate Acetyl-CoA Enrichment Palmitate FNS Stearate FNS Oleate
Control 25.4 ± 0.4 0.118 ± 0.001 7.9 ± 0.2 1.5 ± 0.1
FR 31.0 ± 0.1* 0.133 ± 0.001* 9.2 ± 0.1* 1.7 ± 0.1
*p < 0.05 in comparison with Control group.
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Page 11 of 13novo synthesis contributions from the dams through
nursing. Abnormal lipogenesis is therefore present in FR
adipose tissue during the catch-up growth phase. The
increased lipogenesis may contribute to ultimate devel-
opment of adult obesity.
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